Amundi’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Amundi’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,035	Closed	-$297K	–	2080
2023 Q2	$297K	Sell	7,035 -106,821	-94%	-$4.32M	﹤0.01%	1502
2023 Q1	$3.98M	Sell	113,856 -658,525	-85%	-$23.9M	﹤0.01%	1033
2022 Q4	$26.6M	Buy	772,381 +257,821	+50%	+$10.2M	0.01%	641
2022 Q3	$26.4M	Buy	514,560 +57,512	+13%	+$3.71M	0.02%	633
2022 Q2	$32.3M	Buy	457,048 +90,603	+25%	+$6.62M	0.03%	528
2022 Q1	$31.1M	Buy	366,445 +134,957	+58%	+$11.4M	0.02%	567
2021 Q4	$21.4M	Buy	231,488 +102,224	+79%	+$9.82M	0.01%	663
2021 Q3	$11.3M	Buy	129,264 +124,449	+2,585%	+$11.3M	0.01%	814
2021 Q2	$431K	Buy	+4,815	New	+$407K	﹤0.01%	1289

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amundi's SYNH Position: Q3 2023 in Review

Amundi sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 7,035 shares — an estimated $297K sold.

Amundi first reported a position in SYNH in Q2 2021 and held it in 9 quarters. The position peaked at $32.3M in Q2 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Amundi reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Amundi sold 7,035 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $297K.
Amundi first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 9 quarters.
Amundi's Syneos Health, Inc. Class A Common Stock position peaked at $32.3M in Q2 2022.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.